scholarly journals 184P: The efficacy and safety of amrubicin in non-small-cell lung cancer patients beyond third-line therapy

2016 ◽  
Vol 11 (4) ◽  
pp. S137
Author(s):  
M. Saigusa ◽  
S. Sakurai ◽  
T. Akamatsu ◽  
A. Yamamoto ◽  
Y. Shishido ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Line Therapy ◽  
Third Line Therapy ◽  
Third Line

Efficacy and Safety of Amrubicin in Non-Small-Cell Lung Cancer Patients Beyond Third-Line Therapy

2018 ◽  
Vol 42 (1-2) ◽  
pp. 52-56
Author(s):  
Mika Saigusa ◽  
Kazuhiro Asada ◽  
Taisuke Akamatsu ◽  
Yuko Tanaka ◽  
Yoshinari Endo ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Line Therapy ◽  
Third Line Therapy ◽  
Third Line

Third-Line Therapy for Advanced Non-Small-Cell Lung Cancer Patients: A Feasible Therapeutic Option?

Oncology ◽  
2009 ◽  
Vol 77 (1) ◽  
pp. 113-121 ◽  
Author(s):  
Domenico Galetta ◽  
Antonio Rossi ◽  
Giuseppe Colucci ◽  
Vittorio Gebbia
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Therapeutic Option ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Line Therapy ◽  
Third Line Therapy ◽  
Third Line

scholarly journals Everolimus and Erlotinib as Second- or Third-Line Therapy in Patients with Advanced Non–Small-Cell Lung Cancer

2012 ◽  
Vol 7 (10) ◽  
pp. 1594-1601 ◽  
Author(s):  
Vassiliki A. Papadimitrakopoulou ◽  
Jean-Charles Soria ◽  
Annette Jappe ◽  
Valentine Jehl ◽  
Judith Klimovsky ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Line Therapy ◽  
Third Line Therapy ◽  
Third Line
Sign in / Sign up

Export Citation Format

Share Document